Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1)

BACKGROUND: In patients with mesalazine-refractory ulcerative colitis, systemic corticosteroids are the treatment of choice. OBJECTIVE: To evaluate the efficacy and safety of prolonged release budesonide granules for the induction of remission in patients with mesalazine-refractory ulcerative coliti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:United European Gastroenterol J
Main Authors: Fellermann, Klaus, Schiefke, Ingolf, Rácz, István, Derova, Jelena, Jonaitis, Laimas, Wehrum, Sarah, Nacak, Tanju, Greinwald, Roland
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2020
Assuntos:
Inflammatory Bowel Disease
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724525/
https://ncbi.nlm.nih.gov/pubmed/33028169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620962632
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares